LNSR LENSAR, Inc.
USHealthcareAs of 2026-07-10 13:29
Why LNSR matters now
LENSAR, Inc. (LNSR) is a US stock in Healthcare. The latest InvestLog snapshot shows $6.01 with +1.35% on the session and $72.7M in market capitalization; recent performance reads 1-month -1.03% and YTD -50.64%.
The latest financial table shown here is Q1 2026, with revenue of $13.4M, net income of $36.3M, and EPS of $0.00. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -17.6%.
The latest indexable market news headline is "LENSAR Q1 Earnings Call Highlights" from MarketBeat.
Additional event context on this page matters because analyst consensus is Buy with a median target of $10.00; recent insider activity includes LINK WILLIAM J PHD filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.84
P/S
1.20
EV/EBITDA
1.75
DCF Value
$-53.48
FCF Yield
-17.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.3%
Operating Margin
-28.7%
Net Margin
50.9%
ROE
-514.9%
ROA
44.4%
ROIC
-33.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $13.4M | $36.3M | $0.00 |
| Q4 2025 | $16.0M | $-1.5M | $-0.12 |
| FY 2025 | $58.4M | $-34.3M | $-2.87 |
| Q3 2025 | $14.3M | $-3.7M | $-0.31 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$10.00
Target (Median)
$10.00
Target Range
$10.00 - $10.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.87
LENSAR, Inc. is an established medical device company that specializes in the development and commercialization of an advanced femtosecond laser system. This innovative technology is designed for the surgical treatment of cataracts and the precise management of corneal astigmatism, regardless of whether it's pre-existing or a consequence of surgery. The core of their offering, the LENSAR Laser System, incorporates a suite of exclusive technologies. These are specifically engineered to empower surgeons, enhancing surgical precision, optimizing patient visual results, and ensuring both operational efficiency and consistent procedural outcomes. This is achieved through its sophisticated capabilities in imaging, comprehensive procedure planning, adaptable design features, and unparalleled accuracy. Established in 2004, LENSAR, Inc. is headquartered in Orlando, Florida.